Disrupted PI3K subunit p110α signaling protects against pulmonary hypertension and reverses established disease in rodents
Eva Berghausen(University of Cologne), Stephan Rosenkranz(University of Cologne)
Cited by 20
Related Papers
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
|European Heart Journal|2022|3.6k
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
Idiopathic pulmonary arterial hypertension phenotypes determined by cluster analysis from the COMPERA registry
|The Journal of Heart and Lung Transplantation|2020|207
Systematic Evaluation of Anti-apoptotic Growth Factor Signaling in Vascular Smooth Muscle Cells
|Journal of Biological Chemistry|2005|51
Pathobiology, pathology and genetics of pulmonary hypertension: Update from the Cologne Consensus Conference 2018
|International Journal of Cardiology|2018|39